BrioHealth Solutions Revenue and Competitors

Location

N/A

Total Funding

Medical

Industry

Employee Data

  • BrioHealth Solutions has 88 Employees.(i)
  • BrioHealth Solutions grew their employee count by 47% last year.

BrioHealth Solutions's People

NameTitleEmail/Phone
1
VP Clinical Market Development, Eastern USReveal Email/Phone
2
COO and SVP R&DReveal Email/Phone
3
Senior Director, Quality Assurance & Quality SystemsReveal Email/Phone
4
Senior Director, Supply Chain & Global SourcingReveal Email/Phone
5
Director R&DReveal Email/Phone
6
Director Clinical ServicesReveal Email/Phone
7
Director Information TechnologyReveal Email/Phone
8
Director Business PlanningReveal Email/Phone
9
Director Quality AssuranceReveal Email/Phone
10
Director Training and EducationReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A8-27%N/AN/A
#2
$1.7M57104%N/AN/A
#3
N/A2315%$26.1MN/A
#4
$1.7M40%$1.7MN/A
#5
$7.5M2420%N/AN/A
#6
N/A130%$37.9MN/A
#7
N/A13117%N/AN/A
#8
N/A567%N/AN/A
#9
N/A20%N/AN/A
#10
N/A23156%$106MN/A
Add Company

What Is BrioHealth Solutions?

About BrioHealth Solutions\nWe are a global team of like-minded Med-Tech professionals focused on patient centric solutions in a collaborative environment leading to excellent outcomes. We have developed an advanced and unique heart failure therapy technology in the BrioVAD® Left Ventricular Assist System (LVAS). We are introducing the BrioVAD LVAS to Heart Failure clinicians for use with the large number of indicated and untreated patients who could benefit from chronic mechanical circulatory support. The initiation of our INNOVATE™ Trial in the US is only the beginning. We are building a team to develop advanced technology intended to further improve patient outcomes, increase therapy acceptance, and enabling chronic MCS therapy to be accessible to more patients across the globe. \n \nAbout the BrioVAD® Left Ventricular Assist System (LVAS)* \nLeveraging innovative pump design with long-blade rotor technology, the BrioVAD® LVAS has been designed to create an optimal blood flow path, boosting cardiac output, while minimizing complications. BrioVAD® LVAS’s patient-centric design enhances patient comfort and promotes a sense of vitality and improved well-being. \n \n*The BrioVAD® LVAS is an Investigational Device and limited by Federal law to investigational use.

keywords:N/A

N/A

Total Funding

88

Number of Employees

N/A

Revenue (est)

47%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35.3M88-27%N/A
#2
$1.7M8854%N/A
#3
$27M884%N/A
#4
$18.7M8920%N/A
#5
$12.9M897%N/A